Article Archive - Page 53 of 63 - Business Chemistry

Sector inquiry into the pharmaceutical sector

by | Jan 2008

Introduction More than 8 months ago (on 15 January 2008) the European Commission (“Commission“) launched a sector inquiry into the pharmaceutical sector relating to the introduction of innovative and generic medicines for human consumption onto the market. The...

REACh: A European chemicals regulation with global intersectoral consequences

by | Jan 2008

First of all what is the meaning of REACh? REACh stands for Registration, Evaluation, Authorisation and Restriction of Chemicals and is the new Chemicals Regulation of the European Parliament and Council which entered into force on June 1, 2007. The background of...

Patterns of collaboration along the bio-pharmaceutical innovation process

by | Jan 2008

Abstract Literature has widely acknowledged that creating a tight network of collaborations is an unavoidable strategy for innovative biotech firms. However, few contributions have focused so far on how collaborations along the bio-pharmaceutical innovation process...

The spatial dynamics of the European biotech industry – a NEG approach with vertical linkages

by | Jan 2008

After a period of consolidation, the European biotech industry faces new challenges in the course of increasing internationalization, especially in terms of the EU Eastern enlargement. On one hand, the accession of the new member states opens the emergence of new...

The growing importance of covering payment risks in the chemical industry

by | Jan 2008

The first dark clouds are gathering on the economic horizon of the chemical industry and may cause an unattractive dip in otherwise impressive growth. With the oil price remaining high, concerns that global economic growth is cooling and ever fiercer competition, the...

« Older Entries

Next Entries »